ReSurfX in 2021 – Best-in-class Outcome Predictors, Innovation Catalysts and ROI Multipliers
Once in a rare while, unexpected events leave a major impact on society such as the current COVID-19 pandemic, necessitating additional urgency to create, innovate and be more efficient. That is true for established enterprises and emerging ones alike.
ReSurfX is an ‘outcomes intelligence’ company focused on improving innovation, outcomes, and ROI of enterprises from data-intensive activities, with primary focus on healthcare (Pharma, Biotech and patient care). ReSurfX provides value through significant improvements in accuracy, robustness, novel insights, and advance prediction of outcome directions by leveraging a data-source agnostic novel machine learning (ML) approach we invented – Adaptive Hypersurface Technology (AHT). ReSurfX::vysen is an enterprise software product that delivers these functionalities.
Here we demonstrate the predictive power of AHT based functionalities through an extremely powerful SyRTOP configuration of ReSurfX::vysen product and outline several applications. The rare form of validations provided here are in the form of FDA actions based on Real World Evidence and Post Market Surveillance that are difficult to achieve even with expensive targeted studies.